COMMUNIQUÉS West-GlobeNewswire

Verona Pharma plc: PDMR Dealing
09/08/2019
LONDON, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
ALK announces new epinephrine auto-injector strategy based on innovative new product for the USA
09/08/2019
ALK's ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) new anaphylaxis strategy is to become a major player in the US epinephrine market based on an exclusive deal with Windgap Medical to launch a next generation epinephrine [...]
C-RAD Web Presentation Half-Year Report 2019
09/08/2019
Presentation of the report for the first half of the fiscal year 2019: Date: Friday August 30, 2019 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-year report 2019 Procedure: Please register online through the [...]
Change to the Board of Directors and Executive Leadership Team – appointment of Executive Vice President and CFO
09/08/2019
Read the full announcement in PDF Attachment 2019_29_Change to the BoD_and_Executive_Leadership_Team_EN
Novo Nordisk's operating profit increased by 12% in Danish kroner and by 6% at constant exchange rates (CER) in the first six months of 2019
09/08/2019
Sales increased by 9% in Danish kroner and by 5% at CER to DKK 59.3 billion. Sales in International Operations increased by 13% in Danish kroner (12% at CER), driven by growth in all regions. Sales in North America [...]
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 13-14, 2019
09/08/2019
Geneva, Switzerland and Boston, MA – August 9, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Santhera Announces Executive Management Change
09/08/2019
Pratteln, Switzerland, August 9, 2019 – Santhera Pharmaceuticals (SIX: SANN) announces that Christoph Rentsch has decided to step down as Chief Financial Officer of Santhera by end of this year, in order to pursue his [...]
Stemline Therapeutics Announces Pricing of $76,250,000 Public Offering of Common Stock
09/08/2019
NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc . (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology [...]
Paul Guerrino of Guerrino Dentistry Welcomes Dr. Paul Grunseich As Our Newest Team Member
09/08/2019
Guerrino Dentistry is pleased to announce that experienced cosmetic dentist, Dr. Paul Grunseich, has joined our NY-based dental practice. New York City, NY, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Previously a general dentist [...]
Kohlberg closes on acquisition of Bemis Healthcare Packaging Europe; Merges with Nelipak
09/08/2019
CRANSTON, R.I., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Nelipak® Corporation, Inc. (“Nelipak”), a leading provider of custom designed packaging for the medical device and pharmaceutical industries, announced today that [...]
Stedical Scientific Announces Completion of Acquisition of PermeaDerm, Inc.
09/08/2019
Stedical Scientific embarks on its mission to accelerate global distribution of disruptive innovations in healthcare SAN DIEGO and SHANGHAI, China, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Stedical Scientific announced that it [...]
Silk Road Medical Announces Pricing of Upsized Public Offering
09/08/2019
SUNNYVALE, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing [...]
Lexicon Pharmaceuticals Announces Publication of Positive Data for Zynquista™ (Sotagliflozin) on Cardiorenal Clinical Biomarkers in Adults With Type 1 Diabetes
08/08/2019
Changes in Clinical Biomarkers Suggestive of Favorable Effects on Kidney Function in Patients with Type 1 Diabetes Results Recently Published in Diabetes Care THE WOODLANDS, Texas, Aug. 08, 2019 (GLOBE NEWSWIRE) -- [...]
Diffusion Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
08/08/2019
Company Completes $6.28 Million Registered Direct Offering Favorable Data Reported in Glioblastoma Multiforme Phase 3 Run-in Study Phase 2 On-Ambulance TSC Clinical Trial for the Treatment of Stroke Ready to Enroll [...]
Theratechnologies Regains Control Over Distribution Rights to EGRIFTA® Worldwide
08/08/2019
MONTREAL, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that it has regained complete control over distribution rights of EGRIFTA ® worldwide, following [...]
Theratechnologies reprend le contrôle des droits de distribution d’EGRIFTA(MD) à l’échelle mondiale
08/08/2019
MONTRÉAL, 08 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer qu’elle regagne le contrôle entier des droits de distribution d’ EGRIFTA MD à l’échelle mondiale, à [...]
Amarin Announces FDA Notification of Advisory Committee Meeting Planned to be Held in November 2019 in Connection With Vascepa® REDUCE-IT™ sNDA
08/08/2019
PDUFA Date Extension to End of December 2019 Expected Management to Host Conference Call Today at 7:00 p.m. ET BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN [...]
Checkpoint Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
08/08/2019
NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates
08/08/2019
Company is exploring potential strategic opportunities and non-dilutive sources of capital, and partnerships Continued activities of the first Phase 3 clinical trial for celiac disease including the screening and [...]

Pages